266119 people have viewed this drug in the last 60 days
Updated 2025-01-12
| Last Update | 2025-01-12 |
| Register Year | 2023 |
| Product Type | Human |
| Drug Type | NCE |
| Scientific Name | ORITAVANCIN |
| Trade Name | Orbactiv |
| Strength Unit | mg |
| Pharmaceutical Form | Powder for concentrate for solution for infusion |
| Administration Route | Intravenous use |
| Atc Code1 | J01XA05 |
| Atc Code2 | |
| Size | 0 |
| Size Unit | |
| Package Types | Vial |
| Package Size | 3 |
| Legal Status | Prescription |
| Product Control | Uncontrolled |
| Distribute Area | Hospital |
| Public price | $7344.75 |
| Shelf Life | 48 Months |
| Marketing Company | JAZEERA PHARMACEUTICAL INDUSTRIES |
| Marketing Country | Saudi Arabia |
| Manufacture Name | Patheon Italia S.P.A. |
| Manufacture Country | Italy |
| Secondry package manufacture | Jazeera Pharmaceutical Industries (JPI) |
| Main Agent | Jazeera Pharmaceutical Industries (JPI) |
| Secosnd Agent | |
| Third Agent | |
| Visits | 266119 |
Do not forget, after purchasing the medicine, help us determine the price more accurately, press the button below and adjust the price directly
| Name | Price | Visits | Updated |
|---|---|---|---|
| Orbactiv | $7344.75 | 266119 visits | 2025-01-12 |